James Hamilton

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Methylation 83%
3. Barrett Esophagus 77%
4. Hepatocellular Carcinoma 68%
5. Hepatolenticular Degeneration 63%
6. Liver 56%
7. Adenocarcinoma 55%
8. Liver Diseases 46%
9. Epigenomics 43%
10. Coronavirus 38%
11. Esophageal Neoplasms 37%
12. Genes 35%
13. Neoplasms 35%
14. Biomarkers 34%
15. Esophageal Squamous Cell Carcinoma 30%
16. Copper 29%
17. Antiviral Agents 28%
18. Liver Neoplasms 27%
19. Transplant Recipients 24%
20. Hepatocytes 24%
21. Liver X Receptors 24%
22. Tachykinins 23%
23. Stomach Neoplasms 23%
24. Copper Transport Proteins 22%
25. Fatty Liver 22%
26. Tissue Donors 22%
27. MicroRNAs 22%
28. Hepatic Stellate Cells 21%
29. End Stage Liver Disease 21%
30. Non-alcoholic Fatty Liver Disease 20%
31. Ouabain 19%
32. Mortality 19%
33. Nucleosides 18%
34. Liver Cirrhosis 18%
35. Esophagus 18%
36. Somatostatin 18%
37. Hepacivirus 18%
38. Fibrosis 17%
39. Therapeutics 17%
40. DNA 17%
41. Hepatitis B 17%
42. Colonic Neoplasms 16%
43. polo-like kinase 1 15%
44. Carcinogenesis 15%
45. Immunoglobulins 15%
46. Bilirubin 15%
47. Multicenter Studies 15%
48. bromopyruvate 15%
49. Budd-Chiari Syndrome 15%
50. Messenger RNA 15%